The effects of SGLT2 inhibitors on atrial fibrillation recurrence and cardiac function after catheter ablation in patients with atrial fibrillation and heart failure: a retrospective cohort study and meta-analysis - Scorecard - MDSpire

The effects of SGLT2 inhibitors on atrial fibrillation recurrence and cardiac function after catheter ablation in patients with atrial fibrillation and heart failure: a retrospective cohort study and meta-analysis

  • By

  • Xueying Gao

  • Zhanxin Zhang

  • Kexin Chen

  • Yaqiong Jin

  • Fei Chen

  • Jie Zhang

  • Lu Geng

  • Keke Wang

  • Cunliang Gao

  • Li Wang

  • Jingchao Lu

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Influence of SGLT2 Inhibitors on Recurrence of Atrial Fibrillation and Cardiac Function Post-Catheter Ablation in Atrial Fibrillation Patients with Heart Failure: A Retrospective Cohort Analysis and Meta-Study

At a Glance

CategoryDetail
Condition
Key MechanismsRevise to ensure alignment with the source's detailed mechanisms.
Target Population
Care Setting

Key Highlights

  • highlight_1

Guideline-Based Recommendations

Diagnosis

    Management

    • S
    • p
    • e
    • c
    • i
    • f
    • y
    • w
    • h
    • i
    • c
    • h
    • S
    • G
    • L
    • T
    • 2
    • i
    • n
    • h
    • i
    • b
    • i
    • t
    • o
    • r
    • s
    • a
    • r
    • e
    • r
    • e
    • c
    • o
    • m
    • m
    • e
    • n
    • d
    • e
    • d
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients aged 18 years or older with atrial fibrillation and heart failure.

        SGLT2 inhibitors may enhance cardiac performance and reduce arrhythmia recurrence.

        Clinical Best Practices

        • monitoring

        References

        Original Source(s)

        The effects of SGLT2 inhibitors on atrial fibrillation recurrence and cardiac function after catheter ablation in patients with atrial fibrillation and heart failure: a retrospective cohort study and meta-analysis

        • by Xueying Gao, Zhanxin Zhang, Kexin Chen, Yaqiong Jin, Fei Chen, Jie Zhang, Lu Geng, Keke Wang, Cunliang Gao, Li Wang, Jingchao Lu

        • May 1, 2026

        Related Content

        GLP-1 Drugs Tied to Lower Addiction Risk

        In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

        AI Scribes Lag Clinicians on Note Quality

        A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

        ACSM Revises Resistance Training Guidance

        Synthesized evidence clarifies which training variables enhance strength, hypertrophy, and performance.